IDEAYA Biosciences IDYA Balance Sheet (2018-2026)

NASDAQ IDYA
$39.77 -0.20 (-0.50%)
As of: Sep 4, 2026 · 2:22 PM EDT
Reported Financials

IDEAYA Biosciences Quarterly Balance Sheet

Periods 33 quarters
Latest Jun 2026

IDEAYA Biosciences reported total assets of $1309.70M and total liabilities of $110.79M for the quarter ended Jun 2026, up 25.8% year over year. This balance sheet covers 33 quarters of results from Jun 2018 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Balance Sheet Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Assets
Current Assets
Cash & EquivalentsCash & Equiv.
108.43M92.05M55.29M49.11M101.95M68.63M67.24M102.84M151.85M157.02M108.34M183.05M400.28M84.38M130.00M114.64M298.93M112.83M157.52M272.59M
Short-term InvestmentsInvestments (Current)
156.12M154.72M197.31M219.51M284.29M296.20M272.23M390.87M316.90M368.10M590.43M518.61M519.75M591.94M562.51M555.09M487.97M526.56M513.68M556.37M
Cash & Current Investments
264.55M246.77M252.60M268.62M386.24M364.83M339.47M493.72M468.75M525.11M698.77M701.66M920.03M676.32M692.51M669.74M786.89M639.39M671.20M828.96M
Receivables - NetNet Receivables
1.02M1.10M0.70M0.29M3.45M0.20M0.47M0.16M6.70M0.02M0.01M0.00M0.02M0.00M5.97M6.56M15.42M
Receivables - OtherOther Receivables
5.97M6.56M15.42M
Receivables
1.02M1.10M0.70M0.29M3.45M0.20M0.47M0.16M6.70M0.02M0.01M0.00M0.02M0.00M11.95M13.12M30.83M
Prepaid Assets
3.39M3.12M2.75M3.28M3.74M5.41M4.02M7.91M6.73M7.50M10.57M11.52M12.16M13.39M15.36M15.86M15.76M21.37M18.35M19.65M
Current Assets
268.96M251.00M256.05M272.19M393.44M370.45M343.96M501.79M482.18M532.63M709.35M713.18M932.21M689.71M707.87M685.60M802.65M666.73M696.11M864.02M
Non-Current Assets
Property, Plant & Equipment (Net)PP&E (Net)
4.71M4.76M5.27M7.16M6.68M6.51M6.72M6.83M6.19M6.16M6.91M7.12M8.23M8.97M8.87M8.82M8.17M8.22M8.63M8.28M
Long-Term Investments
121.22M121.29M93.63M55.17M7.69M8.32M11.74M16.38M42.39M107.49M242.64M251.07M280.13M405.83M358.67M322.13M349.96M410.30M301.71M413.93M
Other Non-Current Assets
0.22M0.29M0.26M0.11M0.11M0.11M0.11M0.72M0.72M0.76M0.76M0.91M0.91M0.81M0.81M0.81M0.81M1.01M1.28M1.28M
Non-Current Assets
130.48M130.35M102.82M65.82M17.47M17.52M20.79M25.77M50.76M116.68M252.17M260.48M307.66M434.38M392.77M355.67M382.48M442.60M334.24M445.67M
Assets
399.44M381.35M358.87M338.01M410.91M387.97M364.75M527.56M532.94M649.32M961.53M973.66M1,239.87M1,124.09M1,100.64M1,041.27M1,185.14M1,109.32M1,030.35M1,309.70M
Liabilities
Current Liabilities
Accounts Payables
2.15M2.10M3.36M4.23M3.65M4.28M4.38M5.87M5.17M6.60M6.29M15.89M12.57M15.42M17.63M17.27M18.43M17.58M20.74M30.51M
Payables
2.15M2.10M3.36M4.23M3.65M4.28M4.38M5.87M5.17M6.60M6.29M15.89M12.57M15.42M17.63M17.27M18.43M17.58M20.74M30.51M
Accumulated Expenses
11.89M12.32M12.63M16.23M16.99M17.00M17.27M14.69M16.19M18.76M17.52M24.25M28.09M30.35M32.91M37.75M45.26M40.89M43.74M50.98M
Other Accumulated Expenses
7.42M7.86M9.16M11.22M11.20M11.15M12.55M8.48M9.23M10.68M12.22M17.37M19.03M19.96M25.98M28.12M32.88M26.51M33.09M37.98M
Current Leases
1.66M1.70M1.74M1.78M1.83M1.87M1.92M1.96M2.10M1.75M1.15M0.61M0.30M0.31M0.32M0.33M0.34M0.35M1.19M
Current Deferred Revenue
62.18M60.23M49.44M43.87M17.58M8.57M6.25M2.82M1.44M2.17M
Total Current Liabilities
38.64M45.16M56.96M58.09M32.73M31.72M29.82M25.34M24.89M27.10M24.96M40.74M40.66M46.07M50.85M55.34M64.51M58.81M64.83M82.68M
Non-Current Liabilities
Non-Current Deffered Revenue
39.25M31.19M10.21M8.03M7.31M5.18M1.68M
Preferred Stock Liabilities
Operating Leases
3.92M3.48M3.03M2.57M2.10M1.61M1.12M0.61M1.12M2.41M1.87M18.80M18.87M25.66M26.28M26.92M27.57M28.25M28.12M
Other Non-Current Liabilities
0.01M
Total Non-Current Liabilities
81.81M79.83M70.20M68.69M42.14M38.51M30.94M25.95M24.89M28.23M26.22M42.01M59.45M64.94M76.51M81.62M93.10M86.39M93.08M110.79M
Total Liabilities
81.81M79.83M70.20M68.69M42.14M38.51M30.94M25.95M24.89M28.23M26.22M42.01M59.45M64.94M76.51M81.62M93.10M86.39M93.08M110.79M
Shareholder's Equity
Common Equity
317.63M301.51M288.67M269.32M368.77M349.45M333.81M501.61M508.05M621.09M935.31M931.66M1,180.42M1,059.15M1,024.13M959.65M1,092.03M1,022.93M937.27M1,198.90M
Liabilities and Shareholders Equity
399.44M381.35M358.87M338.01M410.91M387.97M364.75M527.56M532.94M649.32M961.53M973.66M1,239.87M1,124.09M1,100.64M1,041.27M1,185.14M1,109.32M1,030.35M1,309.70M
Retained Earnings
-158.54M-176.75M-190.80M-212.82M-211.20M-235.40M-259.04M-287.00M-314.41M-348.36M-387.94M-440.71M-492.53M-622.84M-695.02M-772.51M-653.30M-736.54M-835.10M-947.53M
Treasury Shares